the aid library

LIST OPTIONS

Filter

9458

CH 2: Psychosocial interventions for treatment of behavioural disorders.

World Health Organization (2015) C_WHO

[Updated 2015] SCOPING QUESTION: What is the effectiveness of psychosocial interventions (including caregiver skills training) for behavioural disorders in children and adolescents?

Download (354)

View PDF (384)

Confronting inequalities — Lessons for pandemic responses from 40 years of AIDS
recommended

UNAIDS (2021) C_WHO

2021 UNAIDS Global AIDS Update. UNAIDS report shows that people living with HIV face a double jeopardy, HIV and COVID-19, while key populations and children continue to be left behind in access to HIV services

Download (598)

View PDF (894)

Assessing and managing children at primary health-care facilities to prevent overweight and obesity in the context of the double burden of malnutrition
recommended

World Health Organization WHO (2017) C_WHO

Updates for the integrated management of childhood illness (IMCI) - Guideline. As part of its response to the global epidemic of obesity, WHO has issued guidelines to support primary healthcare workers identify and manage children who are overweight or obese. Specifically, all infants and children ... more

Download (197)

View PDF (436)

TB policies in Malawi

Medicins sans frontieres; Stop TB Partnership (2020) CC2

Malawi Internationally recommended key policies uptake

Download (264)

View PDF (273)

CH 3: Psychosocial interventions, treatment of emotional disorders.

World Health Organization (2015) C_WHO

[Updated 2015] Scoping question: What is the effectiveness of psychosocial interventions, including caregiver skills training, for emotional disorders in children and adolescents?

Download (1097)

View PDF (2736)

Medical Eligibility Criteria Wheel for Contraceptive Use 2015
recommended

World Health Organization (2015)

This 2015 edition not only updates important changes published in the MEC fifth edition, but also includes several user-friendly features and additional supplemental information, in response to requests WHO has received from stakeholders and partners.

Download (291)

View PDF (367)

COVID-19: Chloroquine and hydroxychloroquine research

World Health Organization WHO (2020) C_WHO

This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri... more

Download (240)

View PDF (209)

Guidance on Infection Prevention among Contact Tracers in Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) CC

Africa CDC will coordinate efforts to scale-up contact tracing by more than one million contact tracers. It is therefore critical that these contact tracers are adequately trained and equipped to avoid being infected.

Download (225)

View PDF (417)

Clinical Managment Protocol: COVID-19

Ministry of Health and Family Welfare, Government of India (2020) C1

Updated July 3, 2020

Download (534)

View PDF (578)

Applying humanitarian standards to fight COVID-19

Sphere (2021) C_Sphere

Updated 8 June 2021. Coronavirus is spreading globally. How can individuals, communities, humanitarian actors, local and national authorities best respond to uphold the rights of all affected people?

Download (296)

View PDF (513)

Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended

World Health Organization WHO (2021) C_WHO

The latest update (28 January 2021) includes the following addition and revision: biosafety aspects for working with antigen-detecting rapid diagnostic test; handling new variants of SARS-CoV-2 in the laboratory; updated assay decontamination before disposal; personal protectiv... more

Download (311)

View PDF (585)

Information and Advice for the Home: Be coronavirus safe at school
recommended

Knowledge Translation Unit, University of Cape Town Lung Institute Western Cape Department of Health (2021) CC

Updated May 2021. Manual 4. The Practical Approach to Care Kit – PACK – is used by nurses, doctors and community health workers in their everyday work to care for patients at the clinic and in the community –PACK Adult, PACK Adolescent, PACK Child and PACK Community.PACK Home is designed for p... more

Download (3644)

View PDF (2787)

HIV/AIDS Diagnostics Technology Landscape

UNITAID Secretariat, World Health Organization (2015) C_WHO

Semi-annual Update

Download (266)

View PDF (259)

COVID-19 Vaccine Operational Guidelines

Ministry of Health and Family Welfare, Government of India (2020) C1

Updated 28 December 2020

Download (818)

View PDF (1006)

WHO Interim Protocol: Rapid operations to contain the initial emergence of pandemic influenza

World Health Organization (2007)

Updated 2007

Download (1108)

View PDF (1490)

Message Guide for Ebola Communication. Social Mobilization Sub-Committee

Ministry of Health and Social Welfare, Liberia; Ebola must Go; Healthy Life (2015)

Version 3 Updates: • Safe School reopening • Special Events messages for sporting events and Africa Cup of Nations, Elections and public gatherings and holidays • Safe sex and condom use for Survivors • Cemetery messages The purpose of this guidance package is to provide government a... more

Download (226)

View PDF (348)

What are the challenges to distribute COVID-19 vaccines globally in an equitable manner? Which solutions should we debate?
recommended

Rüppel, T. (2021) CC

Updated 25 January 2021

Download (525)

View PDF (1047)

Notes for the record: Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD)
recommended

World Health Organization WHO (2018) C_WHO

Update 27 Agusut 2018

Download (466)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (258)

View PDF (239)

Ending Aids - Progress towards the 90-90-90 targets

UNAIDS (2017) C2

Global AIDS Update 2017

Confronting inequalities — Lessons for pandemic responses from 40 years of AIDS recommended

Assessing and managing children at primary health-care facilities to prevent overweight and obesity in the context of the double burden of malnutrition recommended

Medical Eligibility Criteria Wheel for Contraceptive Use 2015 recommended

Guidance on Infection Prevention among Contact Tracers in Africa recommended

Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021 recommended

Information and Advice for the Home: Be coronavirus safe at school recommended

What are the challenges to distribute COVID-19 vaccines globally in an equitable manner? Which solutions should we debate? recommended

Notes for the record: Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD) recommended